First-line avelumab for patients with PD-L1-positive metastatic or locally advanced urothelial cancer who are unfit for cisplatin ☆
Titel:
First-line avelumab for patients with PD-L1-positive metastatic or locally advanced urothelial cancer who are unfit for cisplatin ☆
Auteur:
Iacovelli, R. Ciccarese, C. Brunelli, M. Battelli, N. Buttigliero, C. Caserta, C. Buti, S. Santini, D. Carella, C. Galli, L. Verri, E. Ermacora, P. Merler, S. Masini, C. De Vivo, R. Milesi, L. Spina, F. Rizzo, M. Sperduti, I. Fornarini, G. Tortora, G.